Suppression of hepatitis b virus by a combined activity of CRISPR/Cas9 and HBx proteins

por S. A. Brezgin, A. P. Kostyusheva, V. N. Simirsky, E. V. Volchkova, D. S. Chistyakov, D. S. Kostyushev, V. P. Chulanov
Publicado 2019

Hepatitis B virus and site-specific nucleases: effects of genetic modifications in CRISPR/Cas9 on antiviral activity

por A. P. Kostyusheva, S. A. Brezgin, D. N. Zarifyan, D. S. Chistyakov, V. I. Gegechkory, E O. Bayurova, E. A. Volchkova, D. S. Kostyushev, V. P. Chulanov
Publicado 2019